Physicians prescribing a drug that counteracts arthritis and other inflammatory diseases may in rare cases awaken dormant tuberculosis, researchers report in the Oct. 11 New England Journal of Medicine.
The drug, called infliximab and known by the trade name Remicade, suppresses a protein called tumor necrosis factor-alpha, or TNF-alpha, an immune system protein that causes swelling.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.